A survey of host range genes in poxvirus genomes

Infection, Genetics and Evolution

Volumn 14, Issue 1, 2013, Pages 406-425

  Bratke, Kirsten A ^a   McLysaght, Aoife ^a   Rothenburg, Stefan ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Host range genes; Host pathogen interactions; Poxvirus; Virus evolution

Indexed keywords

F BOX PROTEIN; PROTEIN BCL 2; PROTEIN P28; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

AMINO ACID SEQUENCE; ARTICLE; B5R GENE; BCL 2 GENE; C7L GENE; CONTROLLED STUDY; CRMC GENE; CRMD GENE; CRME GENE; E3L GENE; GENE DELETION; GENE FUNCTION; GENE INACTIVATION; GENE LOSS; HOST RANGE; K3L GENE; M13L GENE; MOUSE; MULTIGENE FAMILY; MYXV GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; POINT MUTATION; POXVIRUS; PRIORITY JOURNAL; PROTEIN FAMILY; SEQUENCE ALIGNMENT; STOP CODON; T4 GENE; TNFR GENE; UNINDEXED SEQUENCE; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; BASE SEQUENCE; COMPUTATIONAL BIOLOGY; EVOLUTION, MOLECULAR; GENES, VIRAL; GENOME, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POXVIRIDAE; SEQUENCE ALIGNMENT; VIRAL TROPISM;

EID: 84873574038     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.12.002     Document Type: Article

References (135)

1. Afonso C.L., Tulman E.R., Delhon G., Lu Z., Viljoen G.J., Wallace D.B., Kutish G.F., Rock D.L. Genome of crocodilepox virus. J. Virol. 2006, 80:4978-4991.
2. Afonso C.L., Tulman E.R., Lu Z., Zsak L., Kutish G.F., Rock D.L. The genome of fowlpox virus. J. Virol. 2000, 74:3815-3831.
3. Alejo A., Ruiz-Arguello M.B., Ho Y., Smith V.P., Saraiva M., Alcami A. A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc. Natl. Acad. Sci. USA 2006, 103:5995-6000.
4. Ali A.N., Turner P.C., Brooks M.A., Moyer R.W. The SPI-1 gene of rabbitpox virus determines host range and is required for hemorrhagic pock formation. Virology 1994, 202:305-314.
5. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
6. Aoyagi M., Zhai D., Jin C., Aleshin A.E., Stec B., Reed J.C., Liddington R.C. Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci. 2007, 16:118-124.
7. Banadyga L., Gerig J., Stewart T., Barry M. Fowlpox virus encodes a Bcl-2 homologue that protects cells from apoptotic death through interaction with the proapoptotic protein Bak. J. Virol. 2007, 81:11032-11045.
8. Barrett J.W., Shun Chang C., Wang G., Werden S.J., Shao Z., Barrett C., Gao X., Belsito T.A., Villenevue D., McFadden G. Myxoma virus M063R is a host range gene essential for virus replication in rabbit cells. Virology 2007, 361:123-132.
9. Barry M., Hnatiuk S., Mossman K., Lee S.F., Boshkov L., McFadden G. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology 1997, 239:360-377.
10. Beattie E., Kauffman E.B., Martinez H., Perkus M.E., Jacobs B.L., Paoletti E., Tartaglia J. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes 1996, 12:89-94.
11. Beattie E., Tartaglia J., Paoletti E. Vaccinia virus-encoded eIF-2α homolog abrogates the antiviral effect of interferon. Virology 1991, 183:419-422.
12. Brandt T., Heck M.C., Vijaysri S., Jentarra G.M., Cameron J.M., Jacobs B.L. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response. Virology 2005, 333:263-270.
13. Brandt T.A., Jacobs B.L. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J. Virol. 2001, 75:850-856.
14. Bratke K.A., McLysaght A. Identification of multiple independent horizontal gene transfers into poxviruses using a comparative genomics approach. BMC Evol. Biol. 2008, 8:67.
15. Carroll K., Elroy-Stein O., Moss B., Jagus R. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J. Biol. Chem. 1993, 268:12837-12842.
16. Chang H.W., Uribe L.H., Jacobs B.L. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. J. Virol. 1995, 69:6605-6608.
17. Chang S.J., Hsiao J.C., Sonnberg S., Chiang C.T., Yang M.H., Tzou D.L., Mercer A.A., Chang W. Poxviral host range protein CP77 contains a F-box-like domain that is necessary to suppress NF-{kappa}B activation by TNF-{alpha} but is independent of its host range function. J. Virol. 2009, 83:4140-4152.
18. Chen N., Li G., Liszewski M.K., Atkinson J.P., Jahrling P.B., Feng Z., Schriewer J., Buck C., Wang C., Lefkowitz E.J., Esposito J.J., Harms T., Damon I.K., Roper R.L., Upton C., Buller R.M. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005, 340:46-63.
19. Chen W., Drillien R., Spehner D., Buller R.M. Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene. Virology 1992, 187:433-442.
20. Chen W., Drillien R., Spehner D., Buller R.M. In vitro and in vivo study of the ectromelia virus homolog of the vaccinia virus K1L host range gene. Virology 1993, 196:682-693.
21. Cooray S., Bahar M.W., Abrescia N.G., McVey C.E., Bartlett N.W., Chen R.A., Stuart D.I., Grimes J.M., Smith G.L. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J. Gen. Virol. 2007, 88:1656-1666.
22. Dar A.C., Sicheri F. X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. Mol. Cell 2002, 10:295-305.
23. Dorfleutner A., Talbott S.J., Bryan N.B., Funya K.N., Rellick S.L., Reed J.C., Shi X., Rojanasakul Y., Flynn D.C., Stehlik C. A Shope Fibroma virus PYRIN-only protein modulates the host immune response. Virus Genes 2007, 35:685-694.
24. Douglas A.E., Corbett K.D., Berger J.M., McFadden G., Handel T.M. Structure of M11L: A myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2. Protein Sci. 2007, 16:695-703.
25. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004, 32:1792-1797.
26. Elde N.C., Child S.J., Geballe A.P., Malik H.S. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 2009, 457:485-489.
27. Engelstad M., Howard S.T., Smith G.L. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 1992, 188:801-810.
28. Engelstad M., Smith G.L. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 1993, 194:627-637.
29. Esposito J.J., Sammons S.A., Frace A.M., Osborne J.D., Olsen-Rasmussen M., Zhang M., Govil D., Damon I.K., Kline R., Laker M., Li Y., Smith G.L., Meyer H., Leduc J.W., Wohlhueter R.M. Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science 2006, 313:807-812.
30. Essbauer S., Pfeffer M., Meyer H. Zoonotic poxviruses. Vet. Microbiol. 2010, 140:229-236.
31. Everett H., Barry M., Lee S.F., Sun X., Graham K., Stone J., Bleackley R.C., McFadden G. M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J. Exp. Med. 2000, 191:1487-1498.
32. Fang Z.Y., Limbach K., Tartaglia J., Hammonds J., Chen X., Spearman P. Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells. Virology 2001, 291:272-284.
33. Fenner F. Adventures with poxviruses of vertebrates. FEMS Microbiol. Rev. 2000, 24:123-133.
34. Gertz E.M., Yu Y.K., Agarwala R., Schaffer A.A., Altschul S.F. Composition-based statistics and translated nucleotide searches: improving the TBLASTN module of BLAST. BMC Biol. 2006, 4:41.
35. Gileva I.P., Nepomnyashchikh T.S., Antonets D.V., Lebedev L.R., Kochneva G.V., Grazhdantseva A.V., Shchelkunov S.N. Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different. Biochim. Biophys. Acta 2006, 1764:1710-1718.
36. Graham S.C., Bahar M.W., Cooray S., Chen R.A., Whalen D.M., Abrescia N.G., Alderton D., Owens R.J., Stuart D.I., Smith G.L., Grimes J.M. Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog. 2008, 4:e1000128.
37. Gubser C., Hue S., Kellam P., Smith G.L. Poxvirus genomes: a phylogenetic analysis. J. Gen. Virol. 2004, 85:105-117.
38. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 2003, 52:696-704.
39. Hnatiuk S., Barry M., Zeng W., Liu L., Lucas A., Percy D., McFadden G. Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis. Virology 1999, 263:290-306.
40. Hu F.Q., Smith C.A., Pickup D.J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 1994, 204:343-356.
41. Huang J., Huang Q., Zhou X., Shen M.M., Yen A., Yu S.X., Dong G., Qu K., Huang P., Anderson E.M., Daniel-Issakani S., Buller R.M., Payan D.G., Lu H.H. The poxvirus p28 virulence factor is an E3 ubiquitin ligase. J. Biol. Chem. 2004, 279:54110-54116.
42. Hughes A.L., Friedman R. Poxvirus genome evolution by gene gain and loss. Mol. Phylogenet. Evol. 2005, 35:186-195.
43. Hughes A.L., Irausquin S., Friedman R. The evolutionary biology of poxviruses. Infect. Genet. Evol. 2010, 10:50-59.
44. Irving J.A., Pike R.N., Lesk A.M., Whisstock J.C. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 2000, 10:1845-1864.
45. Isaacs S.N., Kotwal G.J., Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 1992, 89:628-632.
46. Isaacs S.N., Wolffe E.J., Payne L.G., Moss B. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 1992, 66:7217-7224.
47. Iyer, L.M., Koonin, E.V., Aravind, L., 2002. Extensive domain shuffling in transcription regulators of DNA viruses and implications for the origin of fungal APSES transcription factors. Genome Biol. 3, RESEARCH0012.
48. Johnston J.B., Barrett J.W., Nazarian S.H., Goodwin M., Ricciuto D., Wang G., McFadden G. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 2005, 23:587-598.
49. Katoh K., Misawa K., Kuma K., Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002, 30:3059-3066.
50. Kawagishi-Kobayashi M., Cao C., Lu J., Ozato K., Dever T.E. Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product. Virology 2000, 276:424-434.
51. Kawagishi-Kobayashi M., Silverman J.B., Ung T.L., Dever T.E. Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2a. Mol. Cell. Biol. 1997, 17:4146-4158.
52. Kim Y.G., Muralinath M., Brandt T., Pearcy M., Hauns K., Lowenhaupt K., Jacobs B.L., Rich A. A role for Z-DNA binding in vaccinia virus pathogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:6974-6979.
53. Kotwal G.J., Isaacs S.N., McKenzie R., Frank M.M., Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 1990, 250:827-830.
54. Kotwal G.J., Moss B. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 1988, 335:176-178.
55. Kvansakul M., van Delft M.F., Lee E.F., Gulbis J.M., Fairlie W.D., Huang D.C., Colman P.M. A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak. Mol. Cell 2007, 25:933-942.
56. Kvansakul M., Yang H., Fairlie W.D., Czabotar P.E., Fischer S.F., Perugini M.A., Huang D.C., Colman P.M. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ. 2008, 15:1564-1571.
57. Langland J.O., Jacobs B.L. The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 2002, 299:133-141.
58. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 2006, 119:100-110.
59. Lefkowitz E.J., Upton C., Changayil S.S., Buck C., Traktman P., Buller R.M. Poxvirus Bioinformatics Resource Center: a comprehensive Poxviridae informational and analytical resource. Nucleic Acids Res. 2005, 33:D311-D316.
60. Lefkowitz E.J., Wang C., Upton C. Poxviruses: past, present and future. Virus Res. 2006, 117:105-118.
61. Lewis-Jones S. Zoonotic poxvirus infections in humans. Curr. Opin. Infect. Dis. 2004, 17:81-89.
62. Li Y., Carroll D.S., Gardner S.N., Walsh M.C., Vitalis E.A., Damon I.K. On the origin of smallpox: correlating variola phylogenics with historical smallpox records. Proc. Natl. Acad. Sci. USA 2007, 104:15787-15792.
63. Likos A.M., Sammons S.A., Olson V.A., Frace A.M., Li Y., Olsen-Rasmussen M., Davidson W., Galloway R., Khristova M.L., Reynolds M.G., Zhao H., Carroll D.S., Curns A., Formenty P., Esposito J.J., Regnery R.L., Damon I.K. A tale of two clades: monkeypox viruses. J. Gen. Virol. 2005, 86:2661-2672.
64. Liszewski M.K., Leung M.K., Hauhart R., Buller R.M., Bertram P., Wang X., Rosengard A.M., Kotwal G.J., Atkinson J.P. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J. Immunol. 2006, 176:3725-3734.
65. Liu J., Wennier S., Zhang L., McFadden G. M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells. J. Virol. 2011, 85:3270-3282.
66. Liu Y., Wolff K.C., Jacobs B.L., Samuel C.E. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. Virology 2001, 289:378-387.
67. Loparev V.N., Parsons J.M., Knight J.C., Panus J.F., Ray C.A., Buller R.M., Pickup D.J., Esposito J.J. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. USA 1998, 95:3786-3791.
68. MacNeill A.L., Moldawer L.L., Moyer R.W. The role of the cowpox virus crmA gene during intratracheal and intradermal infection of C57BL/6 mice. Virology 2009, 384:151-160.
69. McFadden G. Poxvirus tropism. Nat. Rev. 2005, 3:201-213.
70. McInnes C.J., Wood A.R., Thomas K., Sainsbury A.W., Gurnell J., Dein F.J., Nettleton P.F. Genomic characterization of a novel poxvirus contributing to the decline of the red squirrel (Sciurus vulgaris) in the UK. J. Gen. Virol. 2006, 87:2115-2125.
71. McLysaght A., Baldi P.F., Gaut B.S. Extensive gene gain associated with adaptive evolution of poxviruses. Proc. Natl. Acad. Sci. USA 2003, 100:15655-15660.
72. Meng X., Chao J., Xiang Y. Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L. Virology 2008, 372:372-383.
73. Meng X., Schoggins J., Rose L., Cao J., Ploss A., Rice C.M., Xiang Y. C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1. J. Virol. 2012, 86:4538-4547.
74. Mercer A.A., Fleming S.B., Ueda N. F-box-like domains are present in most poxvirus ankyrin repeat proteins. Virus Genes 2005, 31:127-133.
75. Meyer H., Sutter G., Mayr A. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 1991, 72(Pt 5):1031-1038.
76. Mosavi L.K., Cammett T.J., Desrosiers D.C., Peng Z.Y. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 2004, 13:1435-1448.
77. Mossman K., Lee S.F., Barry M., Boshkov L., McFadden G. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 1996, 70:4394-4410.
78. Myskiw C., Arsenio J., Hammett C., van Bruggen R., Deschambault Y., Beausoleil N., Babiuk S., Cao J. Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity. J. Virol. 2011, 85:12280-12291.
79. Nerenberg B.T., Taylor J., Bartee E., Gouveia K., Barry M., Fruh K. The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories. J. Virol. 2005, 79:597-601.
80. Newsome T.P., Scaplehorn N., Way M. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 2004, 306:124-129.
81. Nicholls R.D., Gray T.A. Cellular source of the poxviral N1R/p28 gene family. Virus Genes 2004, 29:359-364.
82. Opgenorth A., Graham K., Nation N., Strayer D., McFadden G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 1992, 66:4720-4731.
83. Panus J.F., Smith C.A., Ray C.A., Smith T.D., Patel D.D., Pickup D.J. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. Proc. Natl. Acad. Sci. USA 2002, 99:8348-8353.
84. Peabody D.S. Translation initiation at non-AUG triplets in mammalian cells. J. Biol. Chem. 1989, 264:5031-5035.
85. Perkus M.E., Goebel S.J., Davis S.W., Johnson G.P., Limbach K., Norton E.K., Paoletti E. Vaccinia virus host range genes. Virology 1990, 179:276-286.
86. Pickup D.J., Ink B.S., Parsons B.L., Hu W., Joklik W.K. Spontaneous deletions and duplications of sequences in the genome of cowpox virus. Proc. Natl. Acad. Sci. USA 1984, 81:6817-6821.
87. Postigo A., Cross J.R., Downward J., Way M. Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ. 2006, 13:1651-1662.
88. Ramsey-Ewing A.L., Moss B. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene. Virology 1996, 222:75-86.
89. Reed J.C., Doctor K., Rojas A., Zapata J.M., Stehlik C., Fiorentino L., Damiano J., Roth W., Matsuzawa S., Newman R., Takayama S., Marusawa H., Xu F., Salvesen G., Godzik A. Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res. 2003, 13:1376-1388.
90. Rivas C., Gil J., Melkova Z., Esteban M., Diaz-Guerra M. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 1998, 243:406-414.
91. Rosengard A.M., Liu Y., Nie Z., Jimenez R. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. USA 2002, 99. 8808-8013.
92. Rothenburg S., Chinchar V.G., Dever T.E. Characterization of a ranavirus inhibitor of the antiviral protein kinase PKR. BMC Microbiol. 2011, 11:56.
93. Rothenburg S., Seo E.J., Gibbs J.S., Dever T.E., Dittmar K. Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nat. Struct. Mol. Biol. 2009, 16:63-70.
94. Saraiva M., Alcami A. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J. Virol. 2001, 75:226-233.
95. Schreiber M., McFadden G. The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-alpha in a species-specific fashion. Virology 1994, 204:692-705.
96. Schreiber M., McFadden G. Mutational analysis of the ligand-binding domain of M-T2 protein, the tumor necrosis factor receptor homologue of myxoma virus. J. Immunol. 1996, 157:4486-4495.
97. Sedger L.M., Osvath S.R., Xu X.M., Li G., Chan F.K., Barrett J.W., McFadden G. Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death. J. Virol. 2006, 80:9300-9309.
98. Senkevich T.G., Koonin E.V., Buller R.M. A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. Virology 1994, 198:118-128.
99. Senkevich T.G., Wolffe E.J., Buller R.M. Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. J. Virol. 1995, 69:4103-4111.
100. Seo E.J., Liu F., Kawagishi-Kobayashi M., Ung T.L., Cao C., Dar A.C., Sicheri F., Dever T.E. Protein kinase PKR mutants resistant to the poxvirus pseudosubstrate K3L protein. Proc. Natl. Acad. Sci. USA 2008, 105:16894-16899.
101. Shisler J.L., Isaacs S.N., Moss B. Vaccinia virus serpin-1 deletion mutant exhibits a host range defect characterized by low levels of intermediate and late mRNAs. Virology 1999, 262:298-311.
102. Shisler J.L., Jin X.L. The vaccinia virus K1L gene product inhibits host NF-κB activation by preventing IκBα degradation. J. Virol. 2004, 78:3553-3560.
103. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W., Pemberton P.A., Remold-O'Donnell E., Salvesen G.S., Travis J., Whisstock J.C. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 2001, 276:33293-33296.
104. Shors S.T., Beattie E., Paoletti E., Tartaglia J., Jacobs B.L. Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha. J. Interferon Cytokine Res. 1998, 18:721-729.
105. Smith C.A., Davis T., Anderson D., Solam L., Beckmann M.P., Jerzy R., Dower S.K., Cosman D., Goodwin R.G. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990, 248:1019-1023.
106. Smith C.A., Davis T., Wignall J.M., Din W.S., Farrah T., Upton C., McFadden G., Goodwin R.G. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 1991, 176:335-342.
107. Smith C.A., Hu F.Q., Smith T.D., Richards C.L., Smolak P., Goodwin R.G., Pickup D.J. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 1996, 223:132-147.
108. Sonnberg S., Fleming S.B., Mercer A.A. Phylogenetic analysis of the large family of poxvirus ankyrin-repeat proteins reveals orthologue groups within and across chordopoxvirus genera. J. Gen. Virol. 2011, 92:2596-2607.
109. Sonnberg S., Seet B.T., Pawson T., Fleming S.B., Mercer A.A. Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes. Proc. Natl. Acad. Sci. USA 2008, 105:10955-10960.
110. Spehner D., Gillard S., Drillien R., Kirn A. A cowpox virus gene required for multiplication in Chinese hamster ovary cells. J. Virol. 1988, 62:1297-1304.
111. Stern R.J., Thompson J.P., Moyer R.W. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response. Virology 1997, 233:118-129.
112. Su J., Wang G., Barrett J.W., Irvine T.S., Gao X., McFadden G. Myxoma virus M11L blocks apoptosis through inhibition of conformational activation of Bax at the mitochondria. J. Virol. 2006, 80:1140-1151.
113. Sutter G., Ramsey-Ewing A., Rosales R., Moss B. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant. J. Virol. 1994, 68:4109-41016.
114. Swofford D.L. Phylogenetic Analysis Using Parsimony (and other methods) version 4 2002, Sinauer Associates Inc., Sunderland, Massachusetts.
115. Takahashi-Nishimaki F., Funahashi S., Miki K., Hashizume S., Sugimoto M. Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins. Virology 1991, 181:158-164.
116. Talavera G., Castresana J. Improvement of phylogenies after removing divergent and ambiguously aligned blocks from protein sequence alignments. Syst. Biol. 2007, 56:564-577.
117. Taylor J.M., Quilty D., Banadyga L., Barry M. The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax. J. Biol. Chem. 2006, 281:39728-39739.
118. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL X windows interface. flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25:4876-4882.
119. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
120. Toth A.M., Zhang P., Das S., George C.X., Samuel C.E. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog. Nucleic Acid Res. Mol. Biol. 2006, 81:369-434.
121. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Kutish G.F., Rock D.L. The genome of canarypox virus. J. Virol. 2004, 78:353-366.
122. Tulman E.R., Delhon G., Afonso C.L., Lu Z., Zsak L., Sandybaev N.T., Kerembekova U.Z., Zaitsev V.L., Kutish G.F., Rock D.L. Genome of horsepox virus. J. Virol. 2006, 80:9244-9258.
123. Turner P.C., Moyer R.W. Poxvirus immune modulators: functional insights from animal models. Virus Res. 2002, 88:35-53.
124. Upton C., Macen J.L., Schreiber M., McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 1991, 184:370-382.
125. Upton C., Schiff L., Rice S.A., Dowdeswell T., Yang X., McFadden G. A poxvirus protein with a RING finger motif binds zinc and localizes in virus factories. J. Virol. 1994, 68:4186-4195.
126. van Gent D., Sharp P., Morgan K., Kalsheker N. Serpins: structure, function and molecular evolution. Int. J. Biochem. Cell Biol. 2003, 35:1536-1547.
127. Wang G., Barrett J.W., Nazarian S.H., Everett H., Gao X., Bleackley C., Colwill K., Moran M.F., McFadden G. Myxoma virus M11L prevents apoptosis through constitutive interaction with Bak. J. Virol. 2004, 78:7097-7111.
128. Wang G., Barrett J.W., Stanford M., Werden S.J., Johnston J.B., Gao X., Sun M., Cheng J.Q., McFadden G. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. Proc. Natl. Acad. Sci. USA 2006, 103:4640-4645.
129. Wasilenko S.T., Banadyga L., Bond D., Barry M. The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J. Virol. 2005, 79:14031-14043.
130. Wasilenko S.T., Stewart T.L., Meyers A.F., Barry M. Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis. Proc. Natl. Acad. Sci. USA 2003, 100:14345-14350.
131. Werden S.J., Rahman M.M., McFadden G. Poxvirus host range genes. Adv. Virus Res. 2008, 71:135-171.
132. Wolffe E.J., Isaacs S.N., Moss B. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 1993, 67:4732-4741.
133. Xu X., Nash P., McFadden G. Myxoma virus expresses a TNF receptor homolog with two distinct functions. Virus Genes 2000, 21:97-109.
134. Yang Z., Bruno D.P., Martens C.A., Porcella S.F., Moss B. Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proc. Natl. Acad. Sci. USA 2010, 107:11513-11518.
135. Zhang P., Jacobs B.L., Samuel C.E. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis. J. Virol. 2008, 82:840-848.